Related Experiment Video
Updated: Nov 30, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Advances in the Management of Pediatric Sarcomas
Fiorela N Hernandez Tejada1, Alejandro Zamudio1, Mario L Marques-Piubelli2
1Division of Pediatrics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Purpose Of Review:
The prognosis of pediatric patients who present with metastatic or recurrent sarcomas remains poor. In this review, we summarize the advances in the management of metastatic and relapsed pediatric sarcoma by highlighting recent and future clinical trials.
Recent Findings:
Research into the identification of novel therapies for refractory pediatric sarcomas continues to advance. Outcomes have not improved in several decades underlying a need for improved understanding of the biology behind these tumors and the identification of novel therapeutic molecular targets that can be exploited pharmacologically. Multiple challenges remain for novel therapy in sarcomas such as the selection of effective targets, management of toxicities, and the tumor microenvironment. Many unique challenges remain in the treatment of patients with refractory pediatric sarcomas. Multiple strategies and targets are under investigation that hold promise.
Insights
Pediatric sarcoma patients with metastatic or recurrent disease have a poor prognosis. Advances in novel therapies and clinical trials offer hope for improved outcomes in refractory pediatric sarcomas.
Area of Science:
- Pediatric Oncology
- Sarcoma Research
- Clinical Trials
Background:
- Metastatic and recurrent pediatric sarcomas have a dismal prognosis.
- Decades of research have yielded limited improvement in outcomes for these rare cancers.
- A deeper understanding of sarcoma biology is crucial for developing effective treatments.
Purpose of the Study:
- To review recent advances in managing metastatic and relapsed pediatric sarcoma.
- To highlight current and future clinical trials for pediatric sarcoma.
- To discuss challenges and promising strategies in novel sarcoma therapy.
Main Methods:
- Literature review of recent advancements in pediatric sarcoma management.
- Analysis of ongoing and upcoming clinical trials.
- Discussion of therapeutic targets and challenges.
Main Results:
- Novel therapies for refractory pediatric sarcomas are under active investigation.
- Despite challenges like target selection and toxicity, promising strategies are emerging.
- Research focuses on understanding tumor biology and identifying new molecular targets.
Conclusions:
- Significant challenges persist in treating refractory pediatric sarcomas.
- Ongoing research and clinical trials are essential for improving patient outcomes.
- New therapeutic strategies hold promise for the future of pediatric sarcoma treatment.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

